Scotland · NHS Scotland MSAN
Reboxetine (Edronax®) 4mg tablets
MSAN(2019)20 · Level 2 · issued 22 Nov 2019
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Reboxetine (Edronax®) 4mg tablets will be out of stock from w/c 2 December until w/c 16 | Out of stock | w/c 16 |
| 2. Limited supplies of parallel imports and unlicensed imports are available. | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.